abstract |
A novel method of treating a disease or condition caused or exacerbated by S100A9 activity. A composition for treating a disease or condition caused or exacerbated by S100A9 activity, such as myelodysplastic syndrome (MDS), using a composition comprising an effective amount of a CD33 / S100A9 inhibitor. Things and methods. [Selection diagram] FIG. 1A |